Stock investors of Central Pharmaceuticals have been unsettled after the auditor of the listed drug maker issued an adverse opinion, warning of significant uncertainty over the company’s ability to ...
Fusen Pharmaceutical Co., Ltd. ( ($HK:1652) ) has provided an update. Fusen Pharmaceutical Company Limited has announced a change of auditor, with ...
An announcement from BetterLife Pharma ( ($TSE:BETR) ) is now available. BetterLife Pharma Inc. has announced the resignation of Robert Metcalfe ...
Google’s policy update expands pharmaceutical advertising access in programmatic channels and shifts greater compliance risk ...
The global Temperature Controlled Package for Pharmaceutical market revenue was USD 4215 Million in 2022 and is forecast to a readjusted size of USD 9343.6 Million by 2029 with a CAGR of 11.9% during ...
In a sector where delays can compromise product stability and patient safety, air cargo has assumed a pivotal role in ...
Central Pharmaceuticals Limited could face regulatory sanctions, including penalties, the suspension of trading privileges, or even delisting from the stock exchange, as flagged by the company's ...
Amy Schulman is the second veteran of the pharmaceutical industry that Elevance has added to its board this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback